Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2022-04-04 Legal Proceedings Report
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Legal Proceedings Report 2022
Legal Proceedings Report Classification · 99% confidence The document text is titled "Foreløbig modregnet balance for Orphazyme A/S under rekonstruktion pr. 11. marts 2022/Interim set-off balance of Orphazyme A/S in reconstruction 11 March 2022". It contains detailed financial tables showing assets, liabilities, and calculations related to reconstruction and potential bankruptcy proceedings (indicated by terms like 'rekonstruktion', 'konkurs', 'akkordkreditorer'). This structure, focusing on a specific interim financial position during a restructuring period, strongly suggests a comprehensive financial report for a period shorter than a year, or a specific financial statement related to insolvency proceedings. Given the options, the most fitting category for a comprehensive financial report covering a specific interim period (even if related to reconstruction) is the Interim / Quarterly Report (IR). It is not a general Earnings Release (ER) as it is a detailed balance sheet, nor is it a full Annual Report (10-K). It is a detailed financial statement, not just an announcement of one (RPA/RNS).
2022-04-04 English
Correction: Proposal for a statutory restructuring plan
Regulatory Filings Classification · 95% confidence The document is a short company announcement (3,293 characters) issued by Orphazyme regarding a correction to a previously filed statutory restructuring plan. It explicitly states that it is a correction to a header in an appendix and provides the corrected information. Since it is a brief announcement regarding a regulatory filing/document correction rather than the primary financial report itself, it falls under the category of a general regulatory announcement.
2022-04-04 English
Correction: Proposal for a statutory restructuring plan
Regulatory Filings Classification · 95% confidence The document is a short company announcement (4065 characters) issued by Orphazyme A/S regarding a typographical error in a previously released statutory restructuring plan. It explicitly states that a corrected appendix is attached. Per the 'Menu vs Meal' rule, this is an announcement regarding a report/document rather than the report itself, and it falls under the category of general regulatory announcements/filings.
2022-04-04 Danish
Legal Proceedings Report 2022
Legal Proceedings Report Classification · 99% confidence The document is a 'Company announcement' from 'Orphazyme A/S in restructuring' dated March 31, 2022. The core subject is the 'Proposal for a statutory restructuring plan' which is being submitted to the Danish Maritime and Commercial High Court and sent to creditors for a vote. This announcement explicitly states that the proposal document itself is enclosed/attached ('Please see the enclosed proposal for a statutory restructuring plan including appendices' and lists attachments). Since the document is short (4458 chars) and serves primarily to announce the publication and availability of a detailed legal/financial plan (the restructuring proposal), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive legal filing itself. It is an announcement about a specific corporate action/filing.
2022-03-31 English
Proposal for a statutory restructuring plan
Regulatory Filings Classification · 95% confidence The document is a formal 'Proposal for a restructuring plan' for Orphazyme A/S, filed pursuant to the Danish Insolvency Act. It details the company's financial situation, the purpose of the restructuring, the appointment of an administrator, and includes a preliminary set-off balance sheet. This document is a specific regulatory filing related to insolvency and restructuring proceedings, which does not fit into standard categories like 10-K or ER. Given the nature of the filing as a formal legal and financial notice regarding restructuring, it is best classified as a Regulatory Filing (RNS).
2022-03-31 English
Proposal for a statutory restructuring plan
Legal Proceedings Report Classification · 90% confidence The document is a company announcement regarding a statutory restructuring plan for Orphazyme A/S. It details the submission of a plan to the Danish Maritime and Commercial High Court and mentions an upcoming meeting with creditors. Since this document describes a significant legal and financial restructuring process and does not fit into standard categories like earnings or dividends, it is best classified as a regulatory filing or legal update. Given the specific nature of the restructuring announcement, 'RNS' (Regulatory Filings) is the most appropriate fallback category.
2022-03-31 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.